Board of Directors

EXECUTIVE COMMITTEE


David Main, President & CEO, Aquinox Pharmaceuticals (Chairman)

 

Brad Thompson, President & CEO, Oncolytics Biotech Inc. (Past Chair)


Ron Keefe, President & CEO, Biovectra Inc. (Vice Chair)

 

Vince Lamanna, President, Novo Nordisk Canada Inc. (Treasurer)

Andrew Casey, President & CEO - BIOTECanada (Secretary)
 


MEMBERS


Brian Bloom, President, Bloom Burton & Co.

Natalie Dakers, CEO, CDRD Ventures Inc.

Michel Fortin, President & CEO, Prevtec Microbia Inc.

Diane Gosselin, President & CEO, CQDM

John Haslam, General Manager, Alexion Pharmaceuticals

Kevin Leshuk, General Manager, Celgene Inc.

Mark Lievonen
, President, Sanofi Pasteur Limited

A.J. (Sandy) Marshall, Chairman, Bioindustrial Innovation Canada

Gordon McCauley, Partner, Viable Healthworks Corp.

John Norman, Partner, Gowling Lafleur Henderson LLP

Greg Penner, President & CEO, NeoVentures Biotechnology Inc.

Paul Petrelli, President and General Manager, Canada, Biogen Idec. Canada Inc.

Sanj Sing, President & CEO, Ade Therapeutics

 

Shermaine Tilley, Managing Partner, CTI Life Sciences Fund

 

Eric Tse, General Manager, Shire Pharma Canada ULD

 

Dan Wattier, CEO, ImStar Therapeutics

Partnership Program

Platinum

AbbVie

Biogen Idec

Genzyme

vwr

Gold

Alexion